Skip to main content
SleepCited

마그네슘 글리시네이트 관련 하지불안증후군

F

총 31,304명의 참여자를 대상으로 한 25건의 연구(메타분석 3건, RCT 1건)에 근거합니다. 25건 중 15건의 연구에서 긍정적인 효과가 나타났습니다.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dmagnesium\u002Dglycinate\u0026condition\u003Drestless\u002Dleg\u002Dsyndrome'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

F

결론

Magnesium supplementation may help reduce restless leg syndrome symptoms, especially if you have low magnesium levels, though results vary from person to person.

  • 15 out of 25 studies show positive effects with 31,304 participants across all study types
  • A 2022 RCT showed magnesium plus vitamin B6 alleviated RLS symptoms
  • Low magnesium levels are consistently associated with higher RLS risk
  • Particularly relevant for pregnant women and kidney disease patients with RLS

Key Study Findings

Other
Fresh Genetic Insights Into Micronutrients Influences on Restless Legs Syndrome Risk.
Dose: None vs: None Outcome: Causal association of micronutrients with RLS 효과: Retinol OR 0.46; Mg OR 0.62 None

대상 집단: European ancestry (7248 RLS cases, 19802 controls)

Other
Engineered polyphenol-keratin nanocarriers enhance probiotic delivery and ameliorate obese ulcerative colitis.
Dose: None vs: Uncoated EcN and UC model mice Outcome: UC inflammation and probiotic intestinal retention 효과: None None

대상 집단: Obese C57 mice with DSS-induced UC

Randomized Controlled Trial
Bacterial cellulose matrix and acellular dermal matrix seeded with fibroblasts grown in platelet-rich plasma supplemented …
Dose: BCM or ADM seeded with PRP-grown fibroblasts vs: Free gingival grafts (FGG) Outcome: Wound healing of mucogingival defects 효과: None None

대상 집단: Animal model (mucogingival defects)

Systematic Review
Effects of Dietary Supplementation in Patients with Restless Legs Syndrome: A Systematic Review.
Dose: None vs: None Outcome: Sleep quality 효과: None None

대상 집단: None

In Vitro
Biotechnological properties of Bacillus amylolyquefaciens B65 isolated from an artisanal tannery.
Dose: B. amylolyquefaciens B65 lipopeptides vs: None Outcome: Surfactant and antibacterial properties 효과: None None

대상 집단: In vitro industrial microbiology study

Other n=10 8 weeks Open-label
Magnesium citrate monotherapy improves restless legs syndrome symptoms and multiple suggested immobilization test scores in …
Dose: 200 mg vs: Placebo Outcome: Quality of life 효과: None P = .006

대상 집단: None

Key Statistics

54

연구

8833

참여자

Mixed

F

등급

Referenced Papers

Antioxidants (Basel, Switzerland) 2022 13 인용
The lancet. Diabetes … 2020 2 인용
MMW Fortschritte der … 2013 3 인용
American family physician 2012
Journal of the … 2007 10 인용
Anesthesia and analgesia 2003 1 인용
The American Journal … 1996 1 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
200-400 mg elemental Mg, before bed

상한량: 350 mg/day (supplemental Mg)

연구에서 사용된 용량

용량 기간 효과 N
None -- Mixed --
None -- Positive --
BCM or ADM seeded with PRP-grown fibroblasts -- Positive --
None -- Positive --
B. amylolyquefaciens B65 lipopeptides -- Neutral --
200 mg 8 weeks Mixed 10
5 g -- Positive --
None -- Mixed --

권장 복용 시간: 30-60 minutes before bed

Safety & Side Effects

보고된 부작용

  • Loose stools or diarrhea
  • Nausea
  • Abdominal cramping
  • Low blood pressure at high doses

알려진 상호작용

  • Antibiotics (tetracyclines, fluoroquinolones) — may reduce absorption
  • Bisphosphonates — magnesium may decrease efficacy
  • Blood pressure medications — additive hypotensive effects

일일 최대 섭취 허용량: 350 mg/day (supplemental Mg)

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 마그네슘 글리시네이트 help with 하지불안증후군?
Based on 54 studies with 8,833 participants, there is insufficient evidence at this time that 마그네슘 글리시네이트 may support 하지불안증후군 management. Our evidence grade is F (Evidence Against).
How much 마그네슘 글리시네이트 should I take for 하지불안증후군?
Studies have used various dosages. A commonly studied range is 200-400 mg elemental Mg, before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 마그네슘 글리시네이트?
Reported side effects may include Loose stools or diarrhea, Nausea, Abdominal cramping, Low blood pressure at high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 마그네슘 글리시네이트 and 하지불안증후군?
We rate the evidence as Grade F (Evidence Against). This rating is based on 54 peer-reviewed studies with 8,833 total participants. The overall direction of effect is mixed.

Related Evidence

관련 다른 성분: 하지불안증후군

마그네슘 글리시네이트 다른 건강 상태에 대한 근거

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.